Lego-like gene editing tool lets researchers improve cancer immunotherapy
SAN FRANCISCO, CA—In recent years, scientists have used gene modification technologies to reprogram immune cells into therapeutics that can attack ...
Tag: immunotherapy
In cancer immunotherapy, more isn’t necessarily better
DNA mismatch repair deficiency (MMRd) is a genetic condition often associated with colon cancer. It can happen in otherwise normal ...
Combination immunotherapy treatment effective before lung cancer surgery
Combination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting ...
Uncovering the mechanisms underlying lack of response to immunotherapy
A new study has shed light on why immunotherapy does not always work in certain types of cancer. Led by ...
Trial: Combination immunotherapy prior to lung cancer surgery appears promising
Patients with stage 1–3 non-small cell lung cancer (NSCLC) given a combination immunotherapy prior to surgery (neoadjuvant) had a better ...
Study could help explain why certain brain tumors don’t respond well to immunotherapy
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have ...
Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers
PHILADELPHIA – A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, ...
Sylvester researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy
MIAMI, FLORIDA (EMBARGOED UNTIL AUG. 31, 2023 AT 11 A.M. ET) – Researchers at Sylvester Comprehensive Cancer Center at the ...
Embargoed – Potent oral agent that acts as both immunotherapy and targeted treatment produces high response rate in patients with hard-to-treat and refractory multiple myeloma when combined with steroid, trial shows
EMBARGOED: August 30, 2023, 5PM EST Contact: Nicole Oliverio, 617-257-0454, nicole_oliverio@dfci.harvard.edu Potent Oral Agent That Acts as Both Immunotherapy and ...
New Chinese Medical Journal review summarizes latest research on gamma delta T cells for tumor immunotherapy
Gamma delta (γδ) T cells are a type of unique innate T lymphocytes that are considered to be among the ...
Immunotherapy: Antibody kit to fight tumors
A new study highlights the potential of artificial DNA structures that, when fitted with antibodies, instruct the immune system to ...
Cancer-infecting virus ‘warms up’ cold tumors and improves immunotherapy
Equipping cancer-infecting, or oncolytic, viruses with tumor-inhibiting genetic cargo stimulates the immune system and helps immunotherapy to shrink or completely ...
Gut microbiota and immune alteration in cancer development: implication for immunotherapy
A vast number of microbes colonizes the human body to form an ecological community known as the microbiota. Microbiota are ...
Study raises possibility of immunotherapy treatment for ALS
New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment ...
Biomaterial-delivered one-two punch boosts cancer immunotherapy
By Benjamin Boettner Credit: Wyss Institute at Harvard University By Benjamin Boettner (BOSTON) — Cancer immunotherapy has brought major improvement ...
Immunotherapy for ‘difficult to treat’ lung cancer patients improves long-term survival
A global study, led by UCL and UCLH and sponsored by Roche, has shown that the cancer immunotherapy atezolizumab1 significantly ...
Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients
A new study published in the Journal of the National Cancer Institute brings researchers and oncologists one step closer to ...
A two-for-one approach to boost melanoma immunotherapy
LA JOLLA, CALIF. – July 05, 2023 – New research from Sanford Burnham Prebys has helped explain how melanoma evades ...
Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy
SCIENCE CHINA Life Sciences published a research article online by Professor Yanfeng Gao’s team from the School of Pharmaceutical Sciences ...
UCLA researchers uncover potential biomarkers of positive response to immunotherapy
FINDINGS Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed ...
-
Null results research now published by major behavioral medicine journal
-
New findings on hair loss in men
-
Tirzepatide more effective in blood sugar control and body weight loss than semaglutide, shows meta-analysis of 22 studies
-
Astronomers discover newborn galaxies with the James Webb Space Telescope
-
Chromosome-scale genome sequence of Suaeda glauca sheds light on salt stress tolerance in halophytes
-
ISSCR Kicks off São Paulo International Symposium today in Ribeirão Preto, Brazil